PREDICTION OF RELAPSE IN HYPERTHYROID GRAVES' DISEASE
- 1 May 1980
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 315 (8178), 1101-1103
- https://doi.org/10.1016/s0140-6736(80)91551-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Changes in Thyroid-Stimulating Antibody Activity in Graves' Disease Treated with Antithyroid Drug and Its Relationship to Relapse: A Prospective Study*Journal of Clinical Endocrinology & Metabolism, 1980
- EFFECTS OF RADIOIODINE ON THYROTROPHIN BINDING INHIBITING IMMUNOGLOBULINS IN GRAVES’DISEASEClinical Endocrinology, 1979
- Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*Journal of Clinical Endocrinology & Metabolism, 1979
- A Study of Human Leukocyte D Locus Related Antigens in Graves' DiseaseJCI Insight, 1979
- HLA ANTIGENS IN GRAVES' DISEASEActa Endocrinologica, 1977
- CORRELATION OF HLA AND THYROID ANTIBODIES WITH CLINICAL COURSE OF THYROTOXICOSIS TREATED WITH ANTITHYROID DRUGSThe Lancet, 1977
- VALUE OF THYROID-STIMULATING-ANTIBODY DETERMINATIONS IN PREDICTING SHORT-TERM THYROTOXIC RELAPSE IN GRAVES' DISEASEThe Lancet, 1977
- THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASEThe Lancet, 1974
- THYROTROPHIN-RELEASING HORMONE AS A THYROID-FUNCTION TESTThe Lancet, 1971
- Prediction of the Long-Term Results of Antithyroid Drug Therapy for ThyrotoxicosisJournal of Clinical Endocrinology & Metabolism, 1970